Report Summary
Eternity Insights has published a new study on Global Paclitaxel Market focusing on key segments as by Type (Natural Paclitaxel API, Semi-synthetic Paclitaxel API, Other), by Application (Ovarian Cancer, Cervical Cancer, Breast Cancer, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Paclitaxel Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Paclitaxel Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Paclitaxel Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Paclitaxel Market Segmentation:
Paclitaxel Market, By Type
- Natural Paclitaxel API
- Semi-synthetic Paclitaxel API
- Other
Paclitaxel Market, By Application
- Ovarian Cancer
- Cervical Cancer
- Breast Cancer
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Paclitaxel market in terms of demand generation. The Paclitaxel market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Paclitaxel market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Paclitaxel Market Taxonomy:
To learn more about this report
Global Paclitaxel Market Competitive Landscape
The global Paclitaxel market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Phyton
- ScinoPharm
- Novasep
- Samyang
- Polymed
- TAPI (Teva)
- Fresenius-kabi
- Huiang biopharma
- Southpharma
- Yunnan Hande
- Hainan Yew Pharm
- Jiangsu Yew Biotechnology
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Natural Paclitaxel API, Semi-synthetic Paclitaxel API, Other |
| By Application Outlook |
Ovarian Cancer, Cervical Cancer, Breast Cancer, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Paclitaxel Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Paclitaxel Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Natural Paclitaxel API Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Semi-synthetic Paclitaxel API Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Paclitaxel Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Paclitaxel Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Paclitaxel Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Paclitaxel Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Paclitaxel Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Paclitaxel Market Assessment by Type
8.1 Asia Pacific Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.2 North America Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.3 Europe Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.4 South America Paclitaxel Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Paclitaxel Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Phyton
9.1.1 Phyton Profiles
9.1.2 Phyton Product Portfolio
9.1.3 Phyton Paclitaxel Business Performance
9.1.4 Phyton Paclitaxel Business Development and Market Status
9.2 ScinoPharm
9.2.1 ScinoPharm Profiles
9.2.2 ScinoPharm Product Portfolio
9.2.3 ScinoPharm Paclitaxel Business Performance
9.2.4 ScinoPharm Paclitaxel Business Development and Market Status
9.3 Novasep
9.3.1 Novasep Profiles
9.3.2 Novasep Product Portfolio
9.3.3 Novasep Paclitaxel Business Performance
9.3.4 Novasep Paclitaxel Business Development and Market Status
9.4 Samyang
9.4.1 Samyang Profiles
9.4.2 Samyang Product Portfolio
9.4.3 Samyang Paclitaxel Business Performance
9.4.4 Samyang Paclitaxel Business Development and Market Status
9.5 Polymed
9.5.1 Polymed Profiles
9.5.2 Polymed Product Portfolio
9.5.3 Polymed Paclitaxel Business Performance
9.5.4 Polymed Paclitaxel Business Development and Market Status
9.6 TAPI (Teva)
9.6.1 TAPI (Teva) Profiles
9.6.2 TAPI (Teva) Product Portfolio
9.6.3 TAPI (Teva) Paclitaxel Business Performance
9.6.4 TAPI (Teva) Paclitaxel Business Development and Market Status
9.7 Fresenius-kabi
9.7.1 Fresenius-kabi Profiles
9.7.2 Fresenius-kabi Product Portfolio
9.7.3 Fresenius-kabi Paclitaxel Business Performance
9.7.4 Fresenius-kabi Paclitaxel Business Development and Market Status
9.8 Huiang biopharma
9.8.1 Huiang biopharma Profiles
9.8.2 Huiang biopharma Product Portfolio
9.8.3 Huiang biopharma Paclitaxel Business Performance
9.8.4 Huiang biopharma Paclitaxel Business Development and Market Status
9.9 Southpharma
9.9.1 Southpharma Profiles
9.9.2 Southpharma Product Portfolio
9.9.3 Southpharma Paclitaxel Business Performance
9.9.4 Southpharma Paclitaxel Business Development and Market Status
9.10 Yunnan Hande
9.10.1 Yunnan Hande Profiles
9.10.2 Yunnan Hande Product Portfolio
9.10.3 Yunnan Hande Paclitaxel Business Performance
9.10.4 Yunnan Hande Paclitaxel Business Development and Market Status
9.11 Hainan Yew Pharm
9.12 Jiangsu Yew Biotechnology
10 World Paclitaxel Market Assessment by Players
10.1 Global Paclitaxel Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Paclitaxel Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Paclitaxel Price (USD/Unit) of Players 2014-2020
10.4 Global Paclitaxel Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Paclitaxel Sales Assessment of Players 2014-2020
11.1.2 North America Paclitaxel Revenue Assessment of Players 2014-2020
11.1.3 North America Paclitaxel Price Assessment of Players 2014-2020
11.1.4 North America Paclitaxel Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Paclitaxel Sales Assessment of Players 2014-2020
11.2.2 Europe Paclitaxel Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Paclitaxel Price Assessment of Players 2014-2020
11.2.4 Europe Paclitaxel Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Paclitaxel Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Paclitaxel Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Paclitaxel Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Paclitaxel Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Paclitaxel Sales Assessment of Players 2014-2020
11.4.2 South America Paclitaxel Revenue Assessment of Players 2014-2020
11.4.3 South America Paclitaxel Price Assessment of Players 2014-2020
11.4.4 South America Paclitaxel Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Paclitaxel Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Paclitaxel Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Paclitaxel Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Paclitaxel Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Paclitaxel Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Paclitaxel Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Paclitaxel Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Paclitaxel Sales by Countries/Regions 2014-2020
12.2.2 North America Paclitaxel Revenue by Countries/Regions 2014-2020
12.2.3 North America Paclitaxel Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Paclitaxel Sales by Countries/Regions 2014-2020
12.3.2 Europe Paclitaxel Revenue by Countries/Regions 2014-2020
12.3.3 Europe Paclitaxel Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Paclitaxel Sales by Countries/Regions 2014-2020
12.4.2 South America Paclitaxel Revenue by Countries/Regions 2014-2020
12.4.3 South America Paclitaxel Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Paclitaxel Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Paclitaxel Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Paclitaxel Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Paclitaxel Sales & Revenue Forecast 2021-2026
14.1 World Paclitaxel Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World PaclitaxelSales and Market Share by Regions
14.1.2 World PaclitaxelRevenue and Market Share by Regions
15 Asia Paclitaxel Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Natural Paclitaxel API
15.1.2 Semi-synthetic Paclitaxel API
15.2 Consumption Forecast by Application, 2021-2026
16 North America Paclitaxel Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Natural Paclitaxel API
16.1.2 Semi-synthetic Paclitaxel API
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Paclitaxel Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Natural Paclitaxel API
17.1.2 Semi-synthetic Paclitaxel API
17.2 Consumption Forecast by Application, 2021-2026
18 South America Paclitaxel Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Natural Paclitaxel API
18.1.2 Semi-synthetic Paclitaxel API
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Paclitaxel Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Natural Paclitaxel API
19.1.2 Semi-synthetic Paclitaxel API
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Paclitaxel Price (USD/Unit) Trend 2021-2026
20.2 Global Paclitaxel Gross Profit Trend 2021-2026
21 Conclusion
